References
- Ali S, Jain SK, Abdulla M, Athar M. (1996). Paraquat induced DNA damage by reactive oxygen species. Biochem Mol Biol Int 39:63–7
- Aparicio G, Calvo MB, Medina V, et al. (2009). Comprehensive lung injury pathology induced by mTOR inhibitors. Clin Transl Oncol 11:499–510
- Ashcroft T, Simpson JM, Timbrell V. (1988). Simple method of estimating severity of pulmonay fibrosis on a numerical scale. J Clin Pathol 41:467–70
- Blanco-Ayala T, Anderica-Romero AC, Pedraza-Chaverri J. (2014). New insights into antioxidant strategies against paraquat toxicity. Free Radical Res 48:623–40
- Bridle KR, Popa C, Morgan ML, et al. (2009). Rapamycin inhibits hepatic fibrosis in rats by attenuating multiple profibrogenic pathways. Liver Transpl 15:1315–24
- Chen G, Chen H, Wang C, et al. (2012). Rapamycin ameliorates kidney fibrosis by inhibiting the activation of mTOR signaling in interstitial macrophages and myofibroblasts. PLOS One 7:e33626
- Dinis-Oliveira RJ, Duarte JA, Sánchez-Navarro A, et al. (2008). Paraquat poisonings: mechanisms of lung toxicity, clinical features, and treatment. Crit Rev Toxicol 38:13–71
- Gao Y, Xu X, Ding K, et al. (2013). Rapamycin inhibits transforming growth factor β1-induced fibrogenesis in primary human lung fibroblasts. Yonsei Med J 54:437–44
- Ghaffari AR, Noshad H, Ostadi A, Hasanzadeh N. (2011). Effect of pulse therapy with glucocorticoid and cyclophosphamide in lung fibrosis due to paraquat poisoning in rats. Saudi Med J 32:249–53
- Ghazi-Khansari M, Nasiri G, Honarjoo M. (2005). Decreasing the oxidant stress from paraquat in isolated perfused rat lung using captopril and niacin. Arch Toxicol 79:341–5
- Han JF, Wang SL, He XY, et al. (2006). Effect of genetic variation on human cytochrome p450 reductase-mediated paraquatcytotoxicity. Toxicol Sci 91:42–8
- Hsu RM, Raine L, Fanger H. (1981). The use of antiavidin antibody and avidin-biotin-peroxidase complex in immunoperoxidase techniques. Am J Clin Pathol 75:816–21
- Kahan BD. (2000). Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicenter study. The Rapamune US Study Group. Lancet 356:194–202
- Kelynack KJ, Hewistson TD, Pedagogos E, et al. (1999). Renal myofibroblast contract collagen I matrix lattices in vitro. Am J Nephrol 19:694–701
- Kim JH, Gil HW, Yang JO, et al. (2010). Effect of glutathione administration on serum levels of reactive oxygen metabolites in patients with paraquat intoxication: a pilot study. Korean J Intern Med 2010;25:282–7
- Korfhagen TR, Le Cras TD, Davidson CR, et al. (2009). Rapamycin prevents transforming growth factor-alpha-induced pulmonary fibrosis. Am J Respir Cell Mol Biol 41:562–72
- Lindemann SW, Yost CC, Denis MM, et al. (2004). Neutrophils alter the inflammatory milieu by signal-dependent translation of constitutive messenger RNAs. Proc Nat l Acad Sci USA 101:7076–81
- Lorne E, Zhao X, Zmijewski JW, et al. (2009). Participation of mammalian target of rapamycin complex 1 in toll-like receptor 2- and 4-induced neutrophil activation and acute lung injury. Am J Respir Cell Mol Biol 41:237–45
- Ma XM, Blenis J. (2009). Molecular mehanisms of mTOR-mediated translational control. Nat Rev Mol Cell Biol 10:307–18
- Madala SK, Maxfield MD, Davidson CR, et al. (2011). Rapamycin regulates bleomycin-induced lung damage in SP-C-deficient mice. Pulm Med 2011:653524
- McAlister VC, Gao Z, Peltekian K, et al. (2000). Sirolimus-tacrolimus combination immunosuppression. Lancet 355:376–7
- Mitsopoulos P, Suntres ZE. (2010). Cytotoxicity and gene array analysis of alveolar epithelial A549 cells exposed to paraquat. Chem Biol Interact 188:427–36
- Moses JW, Leon MB, Popma JJ, et al. (2003). Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 349:1315–23
- Neves FF, Sousa RB, Pazin-Filho A, et al. (2010). Severe paraquat poisoning: clinical and radiological findings in a survivor. J Bras Pneumol 36:513–16
- Parvez S, Raisuddin S. (2006). Effects of paraquat on the freshwater fish Channa punctata: non-enzymatic antioxidants as biomarkers of exposure. Arch Environ Contam Toxicol 50:392–87
- Sarbassov DD, Ali SM, Kim DH, et al. (2004). Rictor, a novel binding partner of mTOR, defines a rapamycin insensitive and raptor-independent pathway that regulates the cytoskeleton. Curr Biol 14:1296–302
- Seok SJ, Gil HW, Jeong DS, et al. (2009). Paraquat intoxication in subjects who attempt suicide: why they chose paraquat. Korean J Intern Med 24:247–51
- Sodhi A, Chaisuparat R, Hu J, et al. (2008). The TSC2/mTOR pathway drives endothelial cell transformation induced by the Kaposi’s sarcoma-associated herpesvirus G protein-coupled receptor. Cancer Cell 10:133–43
- Spaulding C, Henry P, Teiger E, et al. (2006). Sirolimus-eluting versus uncoated stents in acute myocardial infarction. N Engl J Med 355:1093–104
- Suntres ZE. (2002). Role of antioxidants in paraquat toxicity. Toxicology 180:65–77
- Tung JN, Lang YD, Wang LF, Chen CM. (2010). Paraquat increases connective tissue growth factor and collagen expression via angiotensin signaling pathway in human lung fibroblasts. Toxicol In Vitro 24:803–8
- Wang BL, Tu YY, Fu JF. (2011). Unbalanced MMP/TIMP-1 expression during the development of experimental pulmonary fibrosis with acute paraquat poisoning. Mol Med Report 4:243–8
- Wesseling C, van Wendel de Joode B, Ruepert C, et al. (2007). Paraquat in developing countries. Int J Occup Environ Health 7:275–86
- Xiong XM, Jiang HL, Liu BF, et al. (2005). Influence of interleukin-10 on the cytokine in acute lung injury in rats induced by endotoxin. Chin J Emerg Med 14:380–3
- Yost CC, Denis MM, Lindermann S, et al. (2004). Activated polymorphonuclear leukocytes rapidly synthesize retinoic acid receptor-a1pha: a mechanism for translational control of transcriptional events. J Exp Med 200:671–80